aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer

Breast Cancer Research

Volumn 5, Issue 6, 2003, Pages

  Cayre, Anne ^a   Rossignol, Fabrice ^b   Clottes, Eric ^b   Penault Llorca, Frédérique ^a  

^a CENTRE JEAN PERRIN   (France)

^b ONERA   (France)

Author keywords

Breast cancer; HIF 1 ; HIF 1 natural antisense; HIF 1 splicing

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TUMOR MARKER; COMPLEMENTARY RNA; HIF1A PROTEIN, HUMAN; ISOPROTEIN; RNA; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; GENETIC TRANSCRIPTION; HIF 1 ALPHA GENE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIMARY TUMOR; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ALTERNATIVE RNA SPLICING; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS;

ALTERNATIVE SPLICING; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, ANTISENSE; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0642275613     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr652     Document Type: Article

References (21)

1. Semenza GL: Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med. 2001, 7: 345-350. 10.1016/S1471-4914(01)02090-1.
2. Page EL, Robitaille GA, Pouyssegur J, Richard DE: Induction of hypoxia-inducible factor-1α by transcriptional and translational mechanisms. J Biol Chem. 2002, 277: 48403-48409. 10.1074/jbc.M209114200.
3. Gothié E, Richard DE, Berra E, Pages G, Pouyssegur J: Identification of alternative spliced variants of human hypoxia-inducible factor-1α. J Biol Chem. 2000, 275: 6922-6927. 10.1074/jbc.275.10.6922.
4. Thrash-Bingham CA, Tartof KD: aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia. J Natl Cancer Inst. 1999, 91: 143-151. 10.1093/jnci/91.2.143.
5. Rossignol F, Vaché C, Clottes E: Natural antisense transcripts of hypoxia-inducible factor-1alpha are detected in different normal and tumour human tissues. Gene. 2002, 299: 135-140. 10.1016/S0378-1119(02)01049-1.
6. L'Allemain G: The hypoxia-inducible factor HIF as a new target in cancer research. Bull Cancer. 2002, 89: 257-260.
7. Sobin LH, Wittekind CH: UICC - TNM classification of malignant tumours. 1998, New York: Wiley-Liss, 5
8. Elston EW, Ellis JO: Methods for grading breast cancer. J Clin Pathol. 1993, 46: 189-190.
9. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza Gl, Simons JW: Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res. 1999, 59: 5830-5835.
10. Bos R, Zhong H, Hanrahan CH, Mommers ECM, Semenza GL, Pinedo Abeloff MD, Simons JW, van Diest PJ, van der Wall E: Levels of hypoxia-inducible factor-1α during breast carcinogenesis. J Natl Cancer Inst. 2001, 93: 309-314. 10.1093/jnci/93.4.309.
11. Semenza GL: HIF-1: using two hands to flip the angiogenic switch. Cancer Metastasis Rev. 2000, 19: 59-65. 10.1023/A:1026544214667.
12. Jacobs TW, Siziopikou KP, Prioleau JE, Raza S, Baum JK, Hayes DF, Schnitt SJ: Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor?. Mod Pathol. 1998, 11: 259-264.
13. Nakayama K, Kanzaki A, Hata K, Katabuchi H, Okamura H, Miyazaki K, Fukumoto M, Takebayashi Y: Hypoxia-inducible factor 1 alpha (HIF-1α) gene expression in human ovarian carcinoma. Cancer Lett. 2002, 176: 215-223. 10.1016/S0304-3835(01)00762-5.
14. Sondergaard KL, Hilton DA, Penney M, Ollerenshaw M, Demaine AG: Expression of hypoxia-inducible factor 1α in tumours of patients with glioblastoma. Neuropath Appl Neurobiol. 2002, 28: 210-217. 10.1046/j.1365-2990.2002.00391.x.
15. Kurebayashi J, Otsuki T, Moriya T, Sonoo H: Hypoxia reduces hormone responsiveness of human breast cancer cells. Jpn J Cancer Res. 2001, 92: 1093-1101.
16. Qin C, Wilson C, Blancher C, Taylor M, Safe S, Harris AL: Association of ARNT splice variants with estrogen receptor-negative breast cancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosis. Clin Cancer Res. 2001, 7: 818-823.
17. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL: HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol. 2001, 21: 3995-4004. 10.1128/MCB.21.12.3995-4004.2001.
18. 18Fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol. 2002, 20: 379-387. 10.1200/JCO.20.2.379.
19. Beasley NJ, Leek R, Alam M, Turley H, Cox GJ, Gatter K, Millard P, Fuggle S, Harris AL: Hypoxia-inducible factors HIF-1α and HIF-2α in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res. 2002, 62: 2493-2497.
20. Elson DA, Ryan HE, Snow JW, Johnson R, Arbeit JM: Coordinate up-regulation of hypoxia inducible factor (HIF)-1α and HIF-1 target genes during multistage epidermal carcinogenesis and wound healing. Cancer Res. 2000, 60: 6189-6195.
21. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK: FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 2002, 16: 1466-1471. 10.1101/gad.991402.